BridgeBio Pharma, Inc. <BBIO.O>: Truist Securities raises target price to $107 from $102
BBIO•Related News
Interface to present at Midwest IDEAS Investor Conference
TILE•
Maase files initial beneficial ownership statement for CTO Zhifeng Li
MAAS•
Collective Mining posts corporate presentation on Colombia-focused exploration portfolio, capital structure
CNL•
Nasdaq Trade Halt <WYHG.O> Volatility Trading Pause at 09:38 AM
WYHG•
Gold gains as markets await key US inflation data
GLD•